New eczema cream aims to clear skin and stop the itch
NCT ID NCT07185282
Summary
This study tested a new ointment called MH004 for people with mild to moderate eczema (atopic dermatitis). It involved 375 teenagers and adults who applied the ointment or a placebo cream twice daily for 8 weeks, followed by a longer safety period. The main goals were to see if the ointment could clear skin, reduce itch, and was safe to use for up to a year.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS (AD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University People's Hospital
Beijing, Beijing Municipality, China
Conditions
Explore the condition pages connected to this study.